Bicycle Therapeutics Plc's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Bicycle Therapeutics Plc's ROA in the second quarter of 2026?
Bicycle Therapeutics Plc recorded a cumulative net loss of $-190 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -27.83%.

However, within the Healthcare sector 410 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 3633, from total ROA ranking in the first quarter of 2026 at 4221.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	-26.71 %	-25.68 %	-24.52 %	-22.99 %	-21.02 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-190	-219	-219	-251	-242
Return On Assets (TTM)	-27.83 %	-29.62 %	-27.51 %	-29.34 %	-26.61 %
BCYC's Total Ranking	# 3633	# 4221	# 3746	# 3713	# 3640
Total Assets (TTM) in million	607	652	718	761	828
Seq. Total Assets Change	-7.03 %	-9.09 %	-5.66 %	-8.08 %	-5.72 %
Seq. Net Income Change	-	-	-	-	-

BCYC's 5 Years Annual ROA >> Back to BCYC Management Effectiveness >> Compare BCYC ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 156
Sector	# 411
Overall	# 3572

Return On Assets Statistics
High	Average	Low
-19 %	-27.57 %	-35.23 %
(Dec 31 2024)		(Dec 31 2020)

Financial Statements
Bicycle Therapeutics Plc's Assets	$ 607 million	BCYC's Balance sheet
Bicycle Therapeutics Plc's Income	$ -50 million	Quarterly BCYC's Income Statement
BCYC's Income by Division		See BCYC's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	-24.47 %	62.86 %	46.77 %	-14.64 %	189.17 %
Total Assets in million	718	950	583	397	466
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-219	-169	-181	-113	-67
Annual Return On Assets	-30.51 %	-17.79 %	-30.97 %	-28.36 %	-14.35 %

BCYC's 5 Years Annual ROA >> Back to BCYC Management Effectiveness >> Compare BCYC ROA to its Competitors

More Return On Assets Ratios
BCYC's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
BCYC's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for BCYC's Competitors
Subscribers only: Roa for Bicycle Therapeutics Plc's Suppliers
Subscribers only: Return On Assets for BCYC's Customers

You may also want to know
BCYC's Roi	BCYC's Inventory Turnover Ratio	BCYC's Growth Rates	BCYC's Dividend Comparisons
	BCYC's Profitability Ratios	BCYC's Asset Turnover Ratio	BCYC's Dividend Growth
BCYC's Roe	BCYC's Valuation Ratios	BCYC's Financial Strength Ratios	BCYC's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-14T03:48:48+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.